Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes.
Goyal
Sameer
S
Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Arora
Sachin
S
Bhatt
Tarun Kumar
TK
Das
Prasenjit
P
Sharma
Amit
A
Kumari
Santosh
S
Arya
Dharamvir Singh
DS
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D001565:Benzoates / Q000494:pharmacology* / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000378:metabolism*; D004195:Disease Models, Animal; D006321:Heart / Q000187:drug effects; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism; D047495:PPAR gamma / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D000077333:Telmisartan
D001562:Benzimidazoles; D001565:Benzoates; D002316:Cardiotonic Agents; D047495:PPAR gamma; D000077333:Telmisartan